Welcome to Iris Biotech
For better service please confirm your country and language we detected.
confirm selection
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorJust a flash away! Employ our novel nitroveratryl-maleimido-beta-alanine linker derivate and generate stable thioether conjugates upon spatiotemporally controllable irradiation with UV light!
lire la suiteTake advantage of our novel pre-loaded Li resins and bring your peptide synthesis to a "greener" level by employing water or other environmentally more friendly solvents!
lire la suiteImprove your work with superparamagnetic iron oxide nanoparticles and get the most out of your research - follow our frequently asked questions for detailed handling insights!
lire la suiteShining light on 4-methoxy-7-nitroindoline (MNI) photocaged aspartate and glutamate building blocks suitable for Fmoc-SPPS. Liberate the sidechain carboxylic acid by irradiation with UV-light of 365 nm.
lire la suiteSPIO (superparamagnetic iron oxide), SPIONs (superparamagnetic iron oxide nanoparticles), IONPs (iron oxide nanoparticles) - read about their advantages and fields of applications!
lire la suiteImprove your click chemistry synthesis with CliCr® - the 7-membered ring strained alkyne TMTHSI is the smallest, most hydrophilic, and highly reactive reagent for copper-free click chemistry.
lire la suiteFlashback! During 2024, plenty of products were added to our product portfolio. Don’t miss innovative technologies and new derivatives! Check out our summary for the second half of the year.
lire la suite